SEIA
SYNH

Signature Estate & Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Signature Estate & Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,074
Closed -$1.4M – 166
2019
Q1 		$1.4M Buy
27,074
+1,045
+4% +$50.7K 0.09% 79
2018
Q4 		$1.02M Buy
+26,029
New +$1.21M 0.09% 89

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Signature Estate & Investment Advisors's SYNH Position: Q2 2019 in Review

Signature Estate & Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 27,074 shares — an estimated $1.4M sold.

Signature Estate & Investment Advisors first reported a position in SYNH in Q4 2018 and held it in 2 quarters. The position peaked at $1.4M in Q1 2019. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

  • Signature Estate & Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 27,074 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $1.4M.
  • Signature Estate & Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 2 quarters.
  • Signature Estate & Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1.4M in Q1 2019.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.